SUSMED,Inc. (TYO:4263)
Japan · Delayed Price · Currency is JPY 405.00
-6.00 (-1.46%)
Oct 6, 2026, 3:30 PM JST
SUSMED,Inc. Market Cap
SUSMED,Inc. has a market cap or net worth of 6.91 billion as of October 5, 2026. Its market cap has decreased by -53.14% in one year.
Market Cap
6.91B
Enterprise Value
3.21B
Revenue
497.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
405.00
ChartMarket Cap Chart
Since December 24, 2021, SUSMED,Inc.'s market cap has decreased from 28.30B to 6.91B, a decrease of -75.58%. That is a compound annual growth rate of -25.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 6.91B | -51.30% |
| Dec 30, 2025 | 14.19B | 39.27% |
| Dec 30, 2024 | 10.19B | -54.23% |
| Dec 29, 2023 | 22.26B | 16.38% |
| Dec 30, 2022 | 19.13B | -41.83% |
| Dec 30, 2021 | 32.88B | 16.21% |
| Dec 24, 2021 | 28.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OncoTherapy Science | 8.16B |
| Chiome Bioscience | 8.05B |
| StemCell Institute | 7.53B |
| J-Pharma | 7.19B |
| ADR Biomedical Holdings | 6.97B |
| MEDINET | 6.81B |
| BrightPath Biotherapeutics | 6.67B |
| Cyfuse Biomedical K.K. | 6.46B |